Plan du site

• VirPath
• Management
• SARS-CoV-2 (2020-2023)
• News - 2023
• News - last semester of 2022
• News - first semester of 2022
• News - last semester of 2021
• News - first semester of 2021
• ------------------------------
• Integrative approach to influenza virus surveillance characterization and control
• • Collaborators
  • Publications
  • Thesis
• ------------------------------
• Molecular and cellular signature of respiratory viruses, innovative antivirals and vaccines
• • Theme #1
  • Theme #2
  • Scientific production
  • • Publications
    • Theses
    • Patents
  • Grants and funding
  • Collaborators
  • Partners
  • Fun
• ------------------------------
• Collaborative projects, Consortiums and Partnership
• ------------------------------
• Virnext spin-off
• VirexpR
• VirHealth SAS
• Signia Therapeutics
• Vaxxel
• ------------------------------
• Contact